Ani Pharmaceuticals (ANIP) Gains from Investment Securities (2022)
Ani Pharmaceuticals' (ANIP) quarterly Gains from Investment Securities came in at $2.5 million in Q3 2022, up 326.12% quarter-over-quarter from -$1.1 million in Q2 2022.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Gains from Investment Securities (2022) Analysis & Trends
Ani Pharmaceuticals has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $2.5 million for Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | 753,000.00 |